Kotyark capacity numbers don't match: 1,500 vs implied 533
In its June concall, Kotyark's prepared remarks claimed Rajasthan capacity rose to 1,500 KLPD. Q&A revealed a 75% increase from current levels implies a baseline of ~533 KLPD. The gap matters for utilization targets.
What's new
- FY26 revenue ₹315 cr, EBITDA ₹48 cr, PAT ₹19 cr at 7-8% utilization.
- Executable OMC order book ₹80 cr, with ₹250 cr pipeline under pursuit.
- Two greenfield facilities (Jhajjar & Kanpur, 200 KLPD each) targeted for December 2026 commissioning.
- Biodiesel export license application in progress, FY27 revenue contribution expected.
Themes from the call
Demand
OMC tenders flat at 15 crore litres per 3 months, but industrial and retail channels accelerating with ARAI certifications unlocking mining and generator segments.
Margins
Current biodiesel margins 8-10% as commodity pricing creates cost-to-price correlation insulating PAT; management sees gradual improvement as utilization rises.
Capital allocation
400 KLPD expansion fully funded through internal accruals; management targets zero-debt status, with in-house design delivering 30% lower capex intensity than competitors.
Guidance watch
- FY27 revenue growth 15-20% with gradual margin improvement from utilization ramp-up.
- 4-5 year vision of 60-80% revenue growth driven by capacity expansion and renewable tailwinds.
- Phased utilization target to reach 60-70% from current 7-8% baseline.
Risk flags
- Capacity claim discrepancy undermines credibility on utilization trajectory and capacity base.
- OMC tender volume flat year-on-year; government blending mandate uncertain amid policy headwinds.
- Legal headwinds include a personal case against management and industry challenge to Supreme Court mandate.
- Isobutanol competitive threat with government support could erode biodiesel demand.
Key quotes
-
"We proactively expanded our biodiesel production capacity at our Rajasthan facility from 500 KLPD to 1,500 KLPD, taking our cumulative annual biodiesel production capacity to approximately 4,80,000 KL."
— Kotyark management, prepared remarks, June 2026 -
"That will increase our capacity by 400 KL per day. It will cover North India for us, representing about a 75% increase from our current levels."
— Kotyark management, Q&A, June 2026
The brief
Kotyark Industries' June concall contained a basic arithmetic inconsistency that investors cannot ignore. In the prepared remarks, management said Rajasthan capacity was expanded from 500 KLPD to 1,500 KLPD during FY26. But in Q&A, they described a 400 KLPD addition as a 75% increase from current levels — which implies a baseline of only ~533 KLPD, not 1,500. The gap is large and was not explained.
Beyond the math problem, the core story is that Kotyark is a capacity-rich but utilization-poor biodiesel producer. FY26 revenue of ₹315 crore came from just 7-8% utilization of its 480,000 KL annual capacity. Management now targets a gradual climb to 60-70% utilization, backed by an ₹80 crore order book and a ₹250 crore pipeline. The near-term catalyst is the industrial channel: recently received ARAI certifications are expected to drive material revenue from mining and generator customers starting this quarter.
Two greenfield facilities in Jhajjar and Kanpur (400 KLPD combined) are due by December 2026, fully funded through internal accruals. Export licensing is also in progress, with management promising FY27 revenue contribution. These moves diversify away from the flat OMC tender business, where volumes have stagnated at 15 crore litres per three months. But the growth trajectory rests on execution against a capacity base that management cannot consistently describe.
The 4-5 year vision of 60-80% revenue growth is plausible if utilization ramps, but the credibility gap on the current capacity baseline needs to be closed first. Investors should demand a clear reconciliation before underwriting the utilization story.
Kotyark's growth story rests on capacity it can't keep straight. The numbers need to add up before the utilization thesis does.